- For years SAP has said that that they were introducing health applications based upon HANA.
- In this article, we review the accuracy of this claim.
What SAP Said About Introducing Health Application Based on HANA
In 2012 both Vishal Sikka and Hasso Plattner stated that SAP was developing a new product for medical research that would leverage HANA. We covered this in the article How Accurate Was Vishal Sikka on the Future of HANA?
In the Diginomica article, Vishal Sikka made a series of outlandish statements, ranging from how SAP was placing genetic algorithms into HANA to help diagnose cancer, to stating that a new medical product was about to be introduced.
What is the Truth About SAP Medical Research Insights?
Over five years later, the “product” that SAP eventually introduced is called SAP Medical Research Insights, and has almost no searches for it in search engines, and does not appear anything like what Vishal Sikka described in 2012. It is a mostly generic analytics solution for medical research that we cover in detail in the article above.
Secondly, there is also no reference to any genetic algorithms being placed in HANA except in one article in 2014 by itelligence, which is an SAP consulting company. SAP was either never doing anything with genetic algorithms in the first place in HANA for health diagnosis, and whatever Vishal Sikka was speaking of evaporated.
Conclusion and Calculation
SAP receives a 10% accuracy rating on its statements regarding its SAP Medical Research Insights.
Link to the Parent Article
This is one of many research articles on a specific topic, that support a larger research calculation. For the overview of the research calculation for all of the SAP topics that were part of the study, see the following primary research A Study into SAP’s Accuracy.
Financial Bias Disclosure
Neither this article nor any other article on the Brightwork website is paid for by a software vendor, including Oracle, SAP or their competitors. As part of our commitment to publishing independent, unbiased research; no paid media placements, commissions or incentives of any nature are allowed.